IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts7577
Avg. Estimate-0.32-0.33-1.35-1.31
Low Estimate-0.34-0.39-1.39-1.49
High Estimate-0.29-0.29-1.23-1.16
Year Ago EPS-0.25-0.33-1.85-1.35
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts5366
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.25-0.28-0.34-0.34
EPS Actual-0.25-0.33-0.37-0.35
Difference0-0.05-0.03-0.01
Surprise %0.00%-17.90%-8.80%-2.90%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.32-0.33-1.35-1.31
7 Days Ago-0.32-0.34-1.35-1.32
30 Days Ago-0.33-0.34-1.37-1.4
60 Days Ago-0.33-0.34-1.37-1.4
90 Days Ago-0.36-0.32-1.42-1.45
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/A1N/A1
Up Last 30 Days2123
Down Last 30 Days1N/A1N/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesIOVAIndustrySectorS&P 500
Current Qtr.-28.00%N/AN/A0.33
Next Qtr.N/AN/AN/A0.40
Current Year27.00%N/AN/A0.16
Next Year3.00%N/AN/A0.12
Next 5 Years (per annum)-19.00%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A